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Background: Community pharmacies are ideally located as a source of support for people with chronic conditions.
Yet, we have limited insight into what innovative pharmacy services would support this consumer group to
manage their condition/s. The aim of this study was to identify what innovations people with chronic conditions
and their carers want from their ideal community pharmacy, and compare with what pharmacists and pharmacy
support staff think consumers want.
Methods: We elicited ideas using the nominal group technique. Participants included people with chronic conditions,
unpaid carers, pharmacists and pharmacy support staff, in four regions of Australia. Themes were identified via
thematic analysis using the constant comparison method.
Results: Fifteen consumer/carer, four pharmacist and two pharmacy support staff groups were conducted.
Two overarching themes were identified: extended scope of practice for the pharmacist and new or improved
pharmacy services. The most innovative role for Australian pharmacists was medication continuance, within a
limited time-frame. Consumers and carers wanted improved access to pharmacists, but this did not necessarily
align with a faster or automated dispensing service. Other ideas included streamlined access to prescriptions via
medication reminders, electronic prescriptions and a chronic illness card.
Conclusions: This study provides further support for extending the pharmacist’s role in medication continuance,
particularly as it represents the consumer’s voice. How this is done, or the methods used, needs to optimise
patient safety. A range of innovative strategies were proposed and Australian community pharmacies should
advocate for and implement innovative approaches to improve access and ensure continuity of care.
Keywords: Pharmacies, Nominal group technique, Prescribing, Innovation, Chronic disease, AustraliaBackground
Similar to other countries, chronic conditions present an
increasing burden in Australia [1]. As medication is
generally needed to treat chronic conditions, pharmacists
can provide further support in this area. Certainly, the
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unless otherwise stated.on Chronic Disease’ [2] comes at a most opportune time.
The call is for pharmacists to expand their scope of
services, thus realising their full potential to assist
people with chronic conditions. While the provision of
professional pharmacy services in Australia has increased,
more needs to be done in preventative care, and to improve
the health of people with a chronic condition [2].
Unpaid carers play an integral role in supporting
people with chronic conditions. There are over 2.7 million
carers in Australia, representing approximately 11.9% of
the population [3]. This role could include managing the
medication of the person they care for [4], hence carersal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Further insight is needed as to how community pharmacy
can support carers, and subsequently, better assist the
care receiver.
In order to be effective, healthcare services need to be
of value to the end user; therefore, people with chronic
conditions need to have more prominence in research
[5]. This raises the question as to what pharmacy
services do people want from community pharmacy to
support them in managing their chronic condition/s.
This is a particularly important question with respect to
innovative pharmacy services, i.e. the introduction of a
new service or approach in pharmacy [6]. In the context
of this study, innovation was further defined to include
the extension of the community pharmacist’s current
role/s or services. Internationally, there have been
significant changes to the pharmacist’s role and the
services that community pharmacies can provide.
This includes the provision of public health services
[7], minor ailments schemes [8], pharmacist-administered
vaccinations [9] and prescribing [10]. While there has
been significant dialogue about extending the roles of
Australian pharmacists [11], this has not eventuated into
practice. There has been, however, research as to whether
Australian residents actually want the types of services
described above. Hoti et al. conducted one of two studies
that explored the public’s view of pharmacist prescribing
[12,13], with the majority of participants accepting
this expanded role within the community pharmacy
setting. Although all study participants were regular
pharmacy users and used at least one prescription
medication, whether carers were involved and the
proportion of participants living in a rural area was
unclear [12]. This is important information, as people
with chronic conditions are likely to have different
experiences and needs to those who are carers. Differences
would also be expected between urban and rural residents
as healthcare access can differ depending on one’s location
in Australia.
Furthermore, is innovation at the community pharmacy
level driven by a clear understanding by pharmacy
staff, i.e. pharmacists and pharmacy support staff, of what
consumers/carers want? There is a need to explore this
further; there is limited knowledge as to what community
pharmacy staff believe people with chronic conditions
and their carers want pharmacy to provide. If there
are incongruent views between consumers, carers and
pharmacy staff, differences will need to be explored
further to ensure that pharmacy staff meet their consumers’
needs. This study aims to identify what innovations people
with chronic conditions and their carers want from
their ideal community pharmacy, and compare this with
what pharmacy staff think consumers want community
pharmacy to provide.Methods
Study participants
Consumer participants with one or more chronic
condition/s, or an unpaid carer for such a person,
were purposively sampled [14], from four Australian
regions; Mount Isa and Logan-Beaudesert (Queensland),
Northern Rivers (New South Wales) and Perth (Western
Australia). These areas vary in terms of accessibility to
pharmacies, i.e. from being highly accessible in Perth,
to modestly or remotely accessible in Mount Isa [15].
Participation included individuals from culturally and
linguistically diverse populations (CALD) and Aboriginal
or Torres Strait Islander peoples (IND).
The health professional groups consisted of either phar-
macists or pharmacy support staff; pharmacy assistants
were included as they are generally the first point of contact
for consumers [16,17]. It was preferable that pharmacists
were currently employed, or had recent experience in the
community pharmacy setting. This ensured that pharma-
cists had up to date knowledge of community pharmacy
practice, and were therefore better placed to answer the
research question. Recruitement for all participants involved
snowball sampling [14] and dissemination of information to
consumer health groups, professional organisations, and
community pharmacies located within the study areas.
Procedure
The nominal group technique [18,19], a highly structured
process which facilitates the generation, discussion and
ranking of participant ideas [20] (Figure 1), was used to
elicit and compare opinions and priorities between con-
sumers, carers and pharmacy staff [20,21]. Participants were
asked to imagine their local pharmacy several years into the
future: what services could they offer to help them to meet
their individual health goals, or to best support them in
their role as a carer? To enable a direct comparison with
the priorities of people with chronic conditions and their
carers, pharmacy staff were directed to reflect on what they
think their consumers would want, not what they would
personally want.
Groups were conducted between December 2012 and
April 2013, audio-recorded and transcribed verbatim. Three
facilitators were deemed necessary to conduct the nominal
groups effectively [22], and these roles were undertaken by
three researchers of varying professional backgrounds, e.g.
public health and pharmacy, as well as a consumer
researcher. Informed consent was obtained from all
participants prior to conducting the nominal groups.
Griffith University Human Research Ethics Committee
(PHM/12/11/HREC) provided study approval.
Data analysis
A ranked list of priorities, i.e. ideas, generated from the
ranking/discussion stage of each group (Figure 1) was
Silent 
generation
•Time to record or think about as many ideas as possible, in 
silence, in response to the question.
Round robin
•Each participant presents one idea at a time and ideas are 
recorded for everyone to see; this continues until there are no
more new ideas.
Clarification
•Opportunity to clarify or elaborate on ideas.
•Recorded items are checked for duplication and possible
grouping.
Ranking and
discussion
•Participants select and rank their top five preferences
•Total scores presented and discussed. 
Figure 1 Adapted version of Nominal Group Technique that is relevant to this study.
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framework was discussed between four researchers who
primarily facilitated the groups, with 23 themes condensed
into 12 over-arching themes [22]. This final framework was
then used to assist both qualitative and quantitative ana-
lysis, of which the latter process is detailed elsewhere [22].
All transcripts were analysed, via the framework, using the
constant comparison method [23] and NVIVO.© This
paper reports the qualitative data relevant to innovative
services and roles, one of the 12 themes identified.
Results
Individuals participated in 15 consumer/carer groups
(n = 103), two pharmacy support staff and four pharmacist
groups (n = 35; Table 1). Participant numbers averaged six
to seven per group (range, 2–14 people). Two over-arching
themes were identified in relation to innovation; extended
scope of practice for the pharmacist, i.e. new roles, and
providing new or improved existing pharmacy services, i.e.
increased access to the pharmacist and other healthcare
professionals, medications, and information (Table 2).
Additional quotes are provided in Table 3.
Extended scope of practice for pharmacists
Medication continuance was the most novel pharmacist
role generated by all groups (consumer, carer, pharmacist
and support staff), with an emphasis on renewing (repeat)medications, not diagnosing a new condition for a
new medication. This role was expressed by some
participants as being able to ‘make’, or ‘renew’ or ‘prescribe’
medication:
Be able to prescribe medicine without a doctor's
prescription… (Consumer_1040; Group_6)
This was deemed useful for people taking medications
regularly, at a consistent dosage, with the proviso of a
limited time-frame, generally up to twelve months from
the doctor’s initial prescription:
…pharmacists should be able to renew prescriptions
for people who are on the same medication year in,
year out, for at least 12 months to take the pressure off
doctors. (Carer_1068; Group_17)
A reason for wanting pharmacists to have this extended
role of medication continuance was to reduce the burden
placed on GPs. Frustration about current practice was
evident from consumer and carer groups, mostly from the
inconvenience of making and attending GP appointments
and their associated cost. Some non-urban participants
described being charged a ‘prescription service’ to obtain
ongoing (repeat) prescriptions when a GP was unavailable.
Pharmacists were also frustrated with the administrative
Table 1 Participant data
Participants
Pharmacists Pharmacy support staff Consumers Carers Mixed consumer/Carer Aboriginal or Torres
Strait Islander peoples
CALD
Location Groups
Logan/Beaudesert (QLD) 1 1 2 1 2 1 1
Mt Isa (QLD) 1 0 1 1 1 1 0
Northern Rivers (NSW) 1 0 2 1 1 1 1
Perth (WA) 1 1 2# 0 1* 1 0
Total 4 2 7 3 5 4 2
n 22 13 54 17 32 35 17
n = total number of participants per group type.
*4 CALD participants participated in mixed consumer/carer group.
#2 CALD participants participated in one of the consumer groups.
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medication, and some consumers and carers did not
understand why certain pharmacies provided an urgent
supply of medication and others did not. This was particu-
larly discussed by CALD participants; some did not
understand why the pharmacist could not provide their
medication when they had no prescription, particularly
when the pharmacist was aware of their medication
history. This resulted in additional stress:
…I was very sick and then the chemist they said no
way [not supplying medication without a
prescription]. And sometime[s] you ring the doctor
and they told you, next day, or one week…
(CALD_Consumer/Carer_1207; Group_13)
The types of medication suggested for continued supply
were mostly those being used long term, such as blood
pressure, insulin and cholesterol medication. Others, mostly
pharmacy assistants, commented about the pharmacist be-
ing able to prescribe antibiotics or medication for simpleTable 2 Innovation themes generated from nominal group pa
EXTENDED SCOPE OF PRACTICE FOR PHARMACISTS • Repeat prescrib
• Minor ailments
• Medication adju
• Point of care te
• Pharmacist-adm
NEW OR IMPROVED EXISTING PHARMACY SERVICES Increased access t
• New services: vi
referrals to spec
• Extended servic
Rolls Royce Serv
Increased access t
• New services: p
chronic illness c
• Extended servic
on prescriptionsailments, thus alleviating the need to see the GP. This was
viewed as a way to facilitate continuity of care for the con-
sumer and reduce the burden on an already busy healthcare
system. To enable this extended role, some consumers
commented on having an agreed treatment plan with the
GP. Carers particularly stressed the need for GP follow up
or collaboration between GPs and pharmacists:
…there can be a danger if they [pharmacist] just
constantly renew it and you're not seeing your doctor.
(Carer_1013; Group_13)
One CALD consumer emphasised that pharmacists
needed further ‘professional freedom’ to be able to do their
job more effectively, i.e. to fully utilise their medication
knowledge. This included the ability to change medication
if there was a side effect, or to alter doses. The provision of
“point of care diagnostics” (Pharmacist_2066; Group_23)
was also mentioned by consumers and pharmacists, par-
ticularly for the monitoring of warfarin, blood glucose,
cholesterol and blood pressure:rticipants
ing (Continuing supply of repeat medication)
scheme (e.g. for antibiotics, urinary tract infections)
stments (e.g. dosing, side-effect concerns)
sting (e.g. blood cholesterol, glucose testing)
inistered vaccinations
o pharmacist or other healthcare professionals
rtual pharmacy consultations, checking technicians, direct
ialists from pharmacists, home visits/community health workers
es: increased number of pharmacists in the pharmacy, forward pharmacy,
ice, co-location with other healthcare professionals/one-stop-shop
o medications and information
rompt dispensing and ordering, e.g. online and dispensing terminals,
ard, drive thru service, service directory, case coordinator
es: information sessions, health promotion, medication indication
, prescription reminder service, home deliveries
Table 3 Additional quotes illustrating themes
Extended scope of practice for pharmacists Repeat prescribing (Continuing supply)
Yeah, the pharmacist should be able to make prescriptions. (Consumer_1208; Group_13)
…they [pharmacists] should be able to renew them but I think perhaps they should collaborate with
the doctor…sometimes medication has changed… (Carer_1149; Group_17)
Pharmacist needs to be able to prescribe medication, at least one that’s been already prescribed, ongoing
medication, like contraception pill, or blood pressure medication. (Pharmacy Assistant_2025; Group_11)
…pharmacists able to supply repeat therapies where appropriate. (Pharmacist_2048; Group 18)
…why should I have to spend $60 going to see the doctor…every time I need a new script? It's daft.
(Consumer_1115; Group_8)
…I think the pharmacist profession is…much limited by legislation…if there is a side-effect for
our medication…he [pharmacist] should be able to replace this medication for you.
(Consumer_1208; Group_13)
…they [pharmacists] can probably do that [prescribe] and free up maybe the system a little bit
better… (Pharmacy support staff_2042; Group_14)
Maybe a two month supply [of medication]. Because out here [rural setting] we have…a lot of
compliance issues because people run out of their scripts…(Pharmacist_2048; Group_18)
Medication adjustments
Pharmacist reviews with the ability to adjust meds [medication] (Pharmacist_2049; Group_18)
New or improved existing pharmacy services Increased access to pharmacist
…they should have an extra chemist on the floor to explain all these things…
(IND_Consumer_1106; Group_4)
Co-location with other healthcare professionals and one-stop shop
…a doctor within the pharmacy, so they come in, we can't do anything about it, straight in to
the doctor” (Pharmacist_2068) “Taking that one step further, have an in-pharmacy setup for [a] virtual
doctor…” (Pharmacist_2062; Group_23)
…go from door to door and see all their health professionals in a one stop shop…
(Pharmacy Support Staff_2024; Group_11)
…have the pharmacy A type class, which is what we have now, and pharmacy B which is the
specialist pharmacy who probably is in a health hub, and that's all they do. They don't sell sunglasses
and they don't sell body stockings, they just dispense and they are highly trained and you probably
pay a bit more… (Carer_1217; Group_15)
Direct pharmacist referrals to health professionals
…refer to professionals and get me into professionals in a timely manner…
(Consumer/Carer_1179; Group_Pilot2)
Community health workers
…indigenous health workers out in the community, follow up the scripts…
(IND_Consumer_2; Group_3)
Prompt dispensing and ordering (online and dispensing terminals)
…a USB script transmitter…some sort of system like a machine at the front or something that you
could access, and bang, bang, bang, this is the script and it goes through to them [pharmacy staff]
with a private password or key…it issues a script, and it will give you an estimated time when you
can come back or it would be ready… (Consumer/Carer_1041; Group_7)
Chronic Illness Card
…a lot of the elders…travel a long way to go to funerals…That card would be priceless if they had
that. So if they went a long distance, go to the chemist, zap it and do whatever they do and the
information is right there for them. Because we all do travel… (IND_Consumer_1158; Group_12)
Prescription Reminder Service
…this is your last repeat, they [pharmacies] should give me a warning…
(CALD_Consumer_1231; Group_21)
Health promotion, information and service directory
Information nights run by pharmacists and doctors for specific health conditions.
(Pharmacist_2053; Group_22)
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has blood pressure and have it automatically tested
when they go to pick up their prescription…
(IND_Consumer_1106; Group_4)
New or improved existing pharmacy services
Increased access to pharmacist or other healthcare professionals
Consumer and carer groups showed interest in pharmacy
as part of a ‘one stop shop’, where the pharmacists “work
very closely in this health hub, or wherever they're situated,
with the other [healthcare] providers…” (Carer_1217;
Group_15). This carer also described having a more
specialised, medical focused pharmacy in Australia, one
that did not sell non-health related products. However, a
pharmacist group thought their consumers would want a
doctor located within a pharmacy, either physically or
virtually. Consumer groups had a similar idea involving
virtual access, but in relation to pharmacy staff. This
involved something like Skype, and was seen as a way to
improve privacy and reduce waiting time, allowing people
who can’t, or don’t want to, physically enter the pharmacy
to still access care:
…rather than having to go and stand and telling my
story in front of everybody else in the shop, I'd like to
have a virtual one where you can have somebody talk to
you on the line and you can just have a face-to-face.
(Consumer/Carer_1118; Group_13)
It was evident that consumers, carers and pharmacy
support staff wanted increased access to other healthcare
professionals in the pharmacy, such as nurse practitioners,
physiotherapists and dieticians, to provide additional
services:
…instead of trying to train a pharmacist…you've got a
nurse practitioner…and they've gone a little bit higher
to get the betterment of qualification to give you the
injection… (Consumer/Carer_1214; Group_13)
Conversely, pharmacists diverged slightly from this view
in relation to nurse-administered vaccinations, with discus-
sion of the pharmacist conducting this role.
Home visits and utilising indigenous community health
workers were discussed by an Aboriginal or Torres Strait
Islander group. This involved monitoring a person’s health-
care and medication usage via community follow ups,
having a yarn and getting to know the person, hence, assist-
ing to ‘close the gap’, i.e. improve the health of Aboriginal
or Torres Strait Islander peoples:
If they see people aren’t coming to the chemist… they
[pharmacist] should make it their business to go out
to their house. (IND_Consumer_1191; Group_3)Increasing the opportunity to speak to a pharmacist was
discussed in different ways via a consumer group, i.e.
increasing pharmacist numbers in a pharmacy, a pharmacy
assistant group, i.e. using checking technicians to relieve
the pharmacist’s dispensing duties, and a pharmacist group,
i.e. working predominantly outside the dispensary (forward
dispensing) and offering a ‘Rolls Royce service’, at a price,
to consumers:
…you always get to talk to your pharmacist and your
scripts are always ready for you so you jump the
queue essentially…and you pay for that.
(Pharmacist_2000; Group_10)
Obtaining specialist referrals from the community
pharmacist was also viewed as a way to improve healthcare
access.Increased access to medications and information
Improving healthcare access was discussed in relation to
medications and information. Pharmacists considered
consumers and carers would want dispensing or ‘script in’
machines, enabling more counselling time with the
pharmacist and providing a faster service:
This is quite controversial, but I think some people
would want automatic dispensing…they'd have a
computer, they'd type in their name and scan the
prescription or something and it just dispenses to you.
(Pharmacist_2068; Group_23)
However, rapid dispensing was not discussed by the
majority of consumers and carers. Only one participant
wanted to be able to dispense their own medication,
another wanted to fast-track the dispensing process
with a system similar to photo processing booths.
Instead, most consumers and carers wanted e-
prescribing, or to be able to request their prescriptions
online. This was emphasised as a way to reduce
pharmacy queues and associated prescription paper-
work, and help people with a physical disability to easily
access their medication:
…online prescriptions. So when the doctor types it out,
why can't it…go straight to the chemist, and then hey
you haven't got…papers to carry around…you can
either go online [to order it]…or by phone…
(Consumer_1037; Group_8)
A chronic illness card was acknowledged as a tool to
facilitate easier access to medication, without ‘the third
degree’, i.e. being asked multiple questions by pharmacy
staff:
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chronic condition…so that the pharmacist knows…
(Consumer/Carer_1206; Group_9)
This idea was also raised by an Aboriginal or Torres
Strait Islander group, with participants describing what
the card would incorporate, including their photo and
medical history, known allergies, doctor/s details, and to
be linked to preventative articles and information about
their condition/s. These participants also thought it would
be particularly useful for elders, especially when they
travel or go ‘walkabout.’ Another participant wanted to
have the medication indication listed on the prescription.
A prescription reminder system such as receiving an
automatic alert when a new prescription was due or
when their medication was running out, was another
extended service suggestion:
…before the due date…get an alert…Because a lot of
elderly people forget… (CALD_Consumer/Carer_1133;
Group_7)
A pick-up and home delivery service was also men-
tioned by some consumers. However, a pharmacist group
perceived that consumers would want an extended service
of being able to obtain medication at any time, day or
night, if needed. While consumer and carer groups did
not request this much access, some did suggest a drive
through service:
You can just drive through with your ID and…here
you go. (Consumer/Carer_1118; Group_13)
Pharmacy support staff thought that consumers would
want a simple service directory that provided information
and contact details of healthcare and support organisations.
However, having a case-coordinator to provide this
information was discussed by consumers and carers:
…accommodate my ideal case coordinator. Because
the pharmacy isn't as intense as, say, even going to
your GP or going to your specialist…house this person
who would then have enough room to bring in guest
speakers…have all the resources there, all the
pamphlets we're needing and information…
(Consumer_1014; Group_15)
Extended services in the form of information evenings
were also seen to be important:
…the more interest and the more education you get
into the pharmacies the better. Because a lot of people
are using the pharmacist instead of their GP.
(Consumer_1116; Group_9)Discussion
This study strengthens support for Australian pharmacists
to expand their scope of practice to include continued
supply of repeat prescriptions. This was described in
numerous ways by participants, with terminology including
prescription renewal and prescribing. However, regardless
of the terminology used, the end result was the same, i.e.
that consumers and carers wanted to obtain a continual
supply of the medication they regularly use, from their
pharmacy, without having to go back to the doctor for a
repeat prescription. Furthermore, pharmacist support staff
and pharmacist groups also thought that consumers and
carers would want this extended pharmacist role; they were
correct in their assumptions.
Currently, when an Australian runs out of their
prescription medication, a pharmacist can assist in the
following ways by [24]:
(i) Contacting the prescriber and obtaining an ‘oral or
faxed prescription.’ The prescriber sends the
prescription to the pharmacist;
(ii) Providing three days (non-government subsidised)
treatment, known as an ‘emergency supply.’ A
follow-up prescription is not required; and
(iii) ‘Continued dispensing’ for one standard pack of
statins and oral contraceptive pills only (e.g. 28 day
supply). This is a relatively new arrangement in
some Australian states and territories.
However, despite the above provisions, this study
suggests that people with chronic conditions and carers
are still having problems obtaining their prescription
medication/s. This issue is linked with the inconsistencies
in quantity and repeat prescription allowances for medi-
cines for chronic conditions, i.e. 28 to 200 days’ supply,
and zero to eleven repeats. Consequently, consumers can
have difficulty synchronising their medications in terms of
needing a new supply or prescription, particularly if they
are taking numerous medications with different quantities
and repeats. Furthermore, a pharmacist group described
that, because of the limited GP appointments available in
their rural area, consumers were being charged for a new
(repeat) prescription without seeing their GP. Consumers
and carers were frustrated with being unable to get a GP
appointment in time, or being charged a fee just to pick
up new prescriptions. While this study did not explore
the experiences of our participants during their GP con-
sultations, it is evident that consumers and carers wanted
a more convenient system by involving the community
pharmacist in prescription reminders and in the continual
supply of their medication.
Groups also raised the issue of obtaining additional
medication without a prescription when consumers had
run out. While legislation permits the supply of up to three
McMillan et al. BMC Health Services Research 2014, 14:476 Page 8 of 9
http://www.biomedcentral.com/1472-6963/14/476days’ medication or a single standard pack if the pack
cannot be broken, e.g. cream, or eye drops, the supply of
greater quantities without a prescription is illegal [25-27].
Our findings indicate that consumers and carers could not
understand why larger quantities, e.g. their usual prescrip-
tion, could not be supplied before the prescription had
been received by the pharmacist, especially when the
pharmacist was aware of their history and need for the
medication. Ultimately, the prescription supply system
could be made safer and more accessible to people by
extending the continued dispensing legislation for
pharmacists [28]. Pharmacists would then be freed
from the conflict between acting within the law and
acting in the patient's best interest. It would also
align with Australia’s National Medicines Policy for
more timely access to medicines [29], especially in rural
and remote areas where time and travel are often barriers
to obtaining healthcare [30]. Continued medication
supply, if conducted appropriately, and collaboratively
with GPs, could allow for more consumer contact with
the pharmacist; something that participants wanted in
this study.
This study cannot provide details with respect to ‘how’
pharmacists could provide a continued supply of
medication to people with chronic conditions. However,
an example of pharmacists working collaboratively with
doctors to assist with medication continuance, and
improve patient convenience, is demonstrated by the
Pharmacy Anti-coagulation Management Services in
New Zealand [31]. Pharmacists can monitor therapy,
review results and provide dose changes under a GP
standing order; prescribing rights are retained by the
GP [32]. Healthcare policy makers and professional
pharmacy bodies should consider two recent Australian
reports documenting the movement towards ‘non-medical
prescribing’ for pharmacists [33,34], a move seen inter-
nationally with supplementary prescribing [35,36]. Our
findings align with aspects of supplementary prescribing,
i.e. that a pharmacist prescribes in accordance to a clinical
management plan, by continuing medication that has
been approved by the patient’s medical prescriber [36].
There were differences in opinions between consumer,
carer and health professional groups. Pharmacy staff
overvalued the importance of rapid dispensing. Generally,
consumer and carer groups did not want innovative
dispensing machines; they wanted improved access to the
pharmacist via new services, such as online, virtual
pharmacy consultations and home visits. Although there
are tele-health services in Australia, eligible healthcare
providers require a Medicare provider number, which
pharmacists currently cannot obtain [37]. Similar issues
exist with home visits or follow-ups; pharmacists can only
obtain re-imbursement if conducting a home medication
review, or alternatively, charge the patient as a privatelyfunded service. Participants also sought streamlined
prescription access via extending services that some
pharmacies may already provide (i.e. improved services),
such as medication or prescription reminders, and elec-
tronic prescriptions, as well as the introduction of a chronic
illness card containing their medical history. Consumers
and carers also wanted easier access to a range of other
healthcare professionals, with some commenting on having
a ‘one-stop shop’, similar to a medical hub. However, this
was described as more for the purposes of convenience
[38]. Pharmacy assistants, not pharmacists, were more
forthcoming with this idea.Strengths and limitations
This paper relies on self-reported data and does not
present the quantitative (i.e. priority lists) results from the
nominal groups. The majority of groups were conducted
during working hours and may not be representative of
people who work or have caring commitments in the day,
e.g. parents. No specific information about the character-
istics of the pharmacy that participants either used or
worked in was sought. However, the nominal group
method did allow people to talk about their experiences,
giving participants an equal say in terms of responding to
the question. Furthermore, this technique allows for the
generation of more than one single idea, i.e. ideas are
maximised and exhausted in each group. As the facilitators
were not independent of the research, there was a risk of
investigator-bias. However, this was done to facilitate the
complex analysis process undertaken by the team
[22]. Furthermore, the methodology used (i.e. nominal
group technique) minimises the influences of the researcher
[39], and a consumer researcher was involved to ground
the findings in consumer experiences.Conclusion
Consumers and carers supported extending the role of
the community pharmacist to include continued medication
supply. Furthermore, this was one idea where views between
the different groups, i.e. consumer, carer and pharmacy staff,
were aligned. Continued medication supply could be via
repeat prescribing or other management services, whichever
method optimises patient safety. Pharmacists need to be
aware that their consumers do not necessarily want a
speedier, automated dispensing service, but seek greater
access to them as a healthcare professional. Consequently,
Australian community pharmacists and the pharmacy
profession should consider these findings, given that they
are what people with chronic conditions and carers want
from their ideal pharmacy.
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